JavaScript is disabled in your browser. Please enable JavaScript for a better experience.
REBALANCE Study
Patients
Healthcare Professionals
Clinical Evidence
Company
Press
Careers
Press
BusinessWire
“May Health Announces Data From Feasibility Studies of its Novel Ovarian Rebalancing™ Treatment and Receives Approval From FDA for Pivotal Trial”
June 26, 2023
Yahoo Finance
“May Health Completes Treatment of Five Participants in U.S. Feasibility Study of its Ovarian Rebalancing Treatment for PCOS-related Infertility”
December 20, 2022
BusinessWire
“May Health Solidifies Veteran Executive Team with Appointment of Women’s Health Care Leader Anne Morrissey as CEO”
September 9, 2022
close
facebook
bars
linkedin
instagram
chevron-down
Code Snippet ma-customfonts 3.4.2
